 |
Justin Petrone is the editor of GenomeWeb's BioArray News and covers the microarray and biochip sector of the genomics market. E-mail Justin Petrone or follow his GenomeWeb Twitter account at @BioArrayNews. |
Agilent Says New CGH IP Reflects 'Dedication' to Cyto Clinical Research Market
August 21, 2012
Agilent Says New CGH IP Reflects 'Dedication' to Cyto Clinical Research Market
Full-text access for premium subscribers only.
Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.
New to GenomeWeb? Register here quickly.
Related Stories
- Agilent, WiCell Offering CGH+SNP Microarray Service
December 4, 2012 / GenomeWeb Daily News - Cytogeneticists Say Platform Choice a Question of Personal Preference, Circumstance
August 21, 2012 / BioArray News - Agilent Develops Method for Single-Cell Analysis on its CGH Microarrays
July 3, 2012 / BioArray News - Agilent Secures First On-array Sequence Capture IP, But Market Impact is Unclear
March 15, 2011 / BioArray News - IP Roundup
February 22, 2011 / BioArray News